Should Patients With High-Risk or Transformed Myelodysplastic Syndrome Proceed Directly to Allogeneic Transplant Without Prior Cytoreduction by Remission-Induction Chemotherapy or Hypomethylating Agent Therapy?
de Witte, Theo M., Bowen, David, Robin, Marie, Malcovati, Luca, Mufti, Ghulam, Niederwieser, Dietger, Yakoubagha, Ibrahim, Kröger, NicolausVolume:
14
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2014.06.015
Date:
September, 2014
File:
PDF, 155 KB
english, 2014
File converter
More search results
More benefits 
